# Juniper Biomedical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/juniper-biomedical

- Industry: Medical Devices & Equipment
- Headquarters: Worcester, US
- Website: www.juniperbiomedical.com/
- Total disclosed funding: $2M
- Latest round: Seed (Apr 2, 2024)
- Investors on record: 3

## About

Based in Massachusetts, US, and founded in 2019 by co-founders David N. Constantine (CEO) and Mario Romero-Ortega, PhD, Juniper Biomedical operates as a pelvic health provider that offers precise neuromodulation therapy to treat pelvic floor disorders, including overactive bladder. In April 2024, Juniper Biomedical raised USD 2 million in seed funding led by Auroral Holdings, with participation from Atma Capital, Hub Angels, and Beacon Angels.

The company offers a battery-powered micro-implant solution that is placed into the pelvic floor and uses precision neuromodulation technology to treat a range of pelvic health conditions, including pelvic pain, sexual dysfunction, urine and bowel incontinence, and other pelvic health conditions.

## Funding rounds

- Seed, Apr 2, 2024, $2M — Hub Angels Investment Group, Beacon Angels, Atma Capital

## Investors

- Hub Angels Investment Group (https://capitalatlas.ai/funds/hub-angels-investment-group) — Seed
- Beacon Angels (https://capitalatlas.ai/funds/beacon-angels) — Seed
- Atma Capital (https://capitalatlas.ai/funds/atma-capital) — Seed